Wang Huiwen

I'm Huiwen

I'm a Computing & Finance undergraduate at NTU, focused on fundamental equity research and building software and hardware systems.

I run a self-directed portfolio specialising in catalyst-driven small- and micro-cap biotech: clinical-trial probabilities, rNPV valuation and cash-runway analysis.

Since April 2024 it has returned +580% on a time-weighted basis, compared with the S&P 500 over the same period.

Recently

  • Following SLS REGAL trial updates for catalyst-driven opportunities
  • Analyst-in-Training, Investment Banking Club (Asset Management)
  • Director, Investment Interactive Club Investment Academy